Clavicular Gorham-Stout disease: a rare case report and literature review - Scorecard - MDSpire

Clavicular Gorham-Stout disease: a rare case report and literature review

  • By

  • Bingyan Mao

  • Qi Peng

  • Jicai Li

  • Zuoquan Qin

  • Shenke Xie

  • Zhiwei Qin

  • July 2, 2026

  • 0 min

Share

Clinical Scorecard: Clavicular Involvement in Gorham-Stout Disease: A Unique Case Study and Review of Existing Literature

At a Glance

CategoryDetail
ConditionGorham-Stout Disease
Key MechanismsIdiopathic osteolytic disorder characterized by progressive bone resorption and vascular or lymphatic hyperplasia.
Target PopulationAdolescents, particularly those with low-energy trauma.
Care SettingClinical evaluation and imaging for diagnosis and management.

Key Highlights

  • Gorham-Stout disease is a rare condition with approximately 400 cases reported worldwide.
  • Diagnosis requires comprehensive evaluation and exclusion of other diseases.
  • Monitoring biochemical markers related to bone turnover is essential for early diagnosis.
  • Early administration of osteoclast activity inhibitors and vitamin D can improve prognosis.
  • Routine internal fixation of fractures without definitive diagnosis may lead to severe consequences.

Guideline-Based Recommendations

Diagnosis

  • Comprehensive evaluation of clinical, imaging, and pathological findings.

Management

  • Individualized treatment plans based on lesion site, patient age, and specific needs.

Monitoring & Follow-up

  • Regular monitoring of biochemical markers related to bone turnover.

Risks

  • Poor prognosis associated with pleural effusion, chylothorax, spinal involvement, or soft tissue invasion.

Patient & Prescribing Data

Adolescents with Gorham-Stout disease and vitamin D deficiency.

Oral treatment regimen initiated, avoiding surgery due to lack of significant functional impairment.

Clinical Best Practices

  • Avoid routine internal fixation of fractures without a definitive diagnosis.
  • Consider early intervention with osteoclast activity inhibitors and vitamin D supplementation.

Related Resources & Content

Original Source(s)

Related Content